Six mixed-practice veterinary surgeons with over 200 combined years of experience have published a book of veterinary tips which they have collected from practising vets all over the UK in order to raise funds for VBF - the charity that supports veterinary professionals.
Alan Jeans, one of the authors, said: "The tips are ideas and techniques that we all use every day in practice but are the kind of thing that you only learn on the job. A range of vets from recent graduates through to veterinary teaching staff have checked the tips for suitability and, although many of the tips are aimed at new or recent graduates, vets of all ages and levels of experience will find plenty of very useful advice.
"The collection started as a 10-tip presentation on an annual CPD sailing trip in Turkey (pictured right) and grew from there. Throughout our careers we have all been impressed by the way that VBF has stepped in to help some of our colleagues in the profession through personal difficulties so we are delighted that we have found a way to fundraise for them."
Nick Short, VBF Director, said: "We are so grateful to all the authors listed in the book for their efforts on VBF's behalf. The tips can either be purchased as a complete collection in paperback by sending a suggested donation of £10 to VBF, 7 Mansfield Street, London W1G 9NQ or you can subscribe to receive regular e-tips on the Vetlife website at www.vetlife.org.uk.
We will also be taking pre-orders at BCVA Congress where VBF is going to be on the BCVA stand this year together with some of the veterinary surgeons who collected the tips.
Bradley Viner reviewed the book. He said: "I defy anyone, however long qualified, to honestly say that they did not learn something worthwhile from this little treasure of a book. And the cartoons are a great giggle as well!"
The book also received good reviews from two BVA Past Presidents. Peter Jinman said: "This little gem of a book is a distillate of the 'art' of veterinary medicine written by those who daily use the science for the benefit of animals under their care." Carl Padgett said: "A great little book. Easy to read and full of those tips that rarely make the covers of academic texts. Tricks old and new that help get the job done written by those that are doing the job."
The course starts in October 2019 and lasts 12 months.
The programme is based around nine days of expert-led small group hands-on practical sessions at CPD Solutions' Training Centre near Birmingham, where participants will develop their existing dentistry skills and learn new techniques.
The company says decision-making is a key focus, as is reflective application of new skills in practice.
CPD Solutions says its PgCerts have unique benefits and differences from other options available, specifically that:
its courses have a stronger emphasis on practical training with all attendance sessions of a practical nature, and no lecture days.
its attendance days are grouped into three sessions rather than the more common monthly attendance.
its programme runs for 12 months, as opposed to many of the alternatives which run for 2-5 years.
Susie Coughlan, Managing Director at CPD Solutions, said: "Our experience is that vets get the most out of hands-on practical training in a structured and supportive environment, combined with reflective application of their new skills in practice.
"We set out to replicate this with the new PgCert in Small Animal Dentistry – all attendance sessions are practical, and the course provides support for developing reflective work-based learning that vets can then use throughout their careers. The format is in keeping with the RCVS CPD focus on outcomes based learning and critical reflective practice."
For more information, ring 0151 328 0444 or visit www.pgcertdent.com
Petplan is calling for nominations for this year's 'Petplan Veterinary Awards 2011'.
The awards, which are now into their 12th year, are an opportunity for colleagues and pet owners to thank their local veterinary stars who go above and beyond the call of duty.
Alison Andrew, Petplan's Marketing Manager, said: "At Petplan, we work closely with vets and hear first hand about the incredible work that is carried out by the profession, so we believe that their invaluable care and support deserves special recognition. Nominating a colleague for an award is a fantastic way of expressing your appreciation for their hard work."
Alison added: "Last year, Petplan was inundated with over 1,800 nominations from across the UK, highlighting that more pet owners understand the great work vets do to help animals and their owners, and with 40% of pet-owners in the UK, stating that they trusted their vet more than their GP, it is not hard to see why the awards are so highly commended."
Closing date for entries is 4th February 2011. All finalists will be invited to a glittering awards ceremony in Birmingham on 31st March 2011, where the winners will be announced.
Winners will be selected based on the evidence given on the nomination forms by veterinary association presidents, so make sure you provide as much information as possible. To nominate today visit www.petplan.co.uk/vetawards
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
The aim of the week is to help pet owners identify common symptoms of eye disease and to seek prompt veterinary attention where appropriate.
To support the initiative, TVM UK is supplying veterinary practices with a kit to create their own waiting room display to inform owners about the common symptoms of eye disease. Pet owners can obtain further, more in-depth information by scanning a QR code on their smartphone camera which takes them directly to the webpage www.tvm-uk.com/eyehealth.
There is also a ‘Who’s Got Their Eye on You’ mini quiz to help engage clients to see if they can spot one of their pets in the animal line up.
Will Peel, Product Manager at TVM UK said: "Eye problems in pets can sometimes be hard for pet owners to pick up so we have launched Pet Eye Health Awareness Week to raise awareness of common symptoms of poor eye heath so problems can be identified early and pet owners can seek veterinary advice quickly."
For more information, contact your local territory manager, email help@tvm-uk.com or call 0800 0385868. You can find additional eye-health related social media content at: www.tvm-uk.com.
Vethelpdirect.com, the website founded by VetSurgeon.org member, Susie Samuel MRCVS, has launched a new system called VetReviews which allows your clients publish a review of your service directly from your own website.
To use the system, you (or perhaps more likely your website person) embed a small form on your website, called a widget, as shown on this example: www.baytreevets.co.uk (bottom right hand side).
Clients then click the link in the widget to submit a review of your practice, or to read existing reviews.
To ensure fair play, each review is checked by a person who removes any spammy or malicious reviews, and looks for any signs of fraudulent multiple reviews being submitted by one person.
In the event of a negative review, the practice is given 5 days to respond before the review is published, which means the review isn't displayed without the practice's side of the story.
However, as Susie points out, a single negative review is not necessarily a bad thing; most people are able to put one bad review into context. Indeed, a small number of negative, or less positive reviews tends to make the glowing ones seem more credible.
VetReviews are optimised for inclusion in Google search results, which should also help your search engine visibility.
For more information about VetReviews (which is a free upgrade for existing customers), email: vets@vethelpdirect.com, or telephone 0845 4961 204.
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
The new formula also contains crataegus, L-carnitine and magnesium taurate, and is designed to be used alongside all heart medications.
Alongside the launch of the new product, Vita has also created an infographic highlighting the common signs of heart disease in dogs.
https://vitaanimalhealth.com/common-signs-of-heart-disease
https://vitaanimalhealth.com/product/omnicardio-plus
Pooch & Mutt has 20x 40-day trials of its new joint & bone supplement, Mobile Bones Concentrate, to give away to veterinary professionals.
Guy Blaskey from Pooch & Mutt said: "At The London Vet Show vets and vet nurses told us that they loved the new Mobile Bones Concentrate because at just £9.99 per month it costs less than other joint supplements (whilst having the same high quality ingredients), it takes up a very small amount of shelf space and it doesn't involve the client having to either change their dog's food or stuff pills down their dog's throat."
In response to requests from vets and vet nurses to try the new joint supplement, Pooch & Mutt have set up a dedicated website at www.jointsupplementfordogs.com where you can apply from one of twenty 40 day trials.
Guy continued, "We did not want to simply send samples out to everyone. By setting up the site we can choose a variety of dogs from different breed and with different conditions to send a full 40-day trial to. We hope to get regular feedback from the vets, vet nurses and dog owners involved in the trial and publish it on http://www.jointsupplementfordogs.com/ for everyone else to see."
The trials are available to all veterinary professionals and can be for their own dogs, or dogs belonging to their clients.
Animalcare has announced the UK and Ireland launch of Vitofyllin, a central nervous system stimulant for older dogs suffering from dullness, poor demeanour and unwillingness to exercise.
The launch of Vitofyllin is the result of a collaboration between Animalcare and three European partners.
The company says the project has enhanced its in-house expertise because the active ingredient for the product was unavailable in the market and had to be contract synthesised, a first for a new product development at Animalcare. The regulatory procedure was also the first time a bioequivalence bio-waiver had been successfully applied for and obtained in Europe. This made the development quicker, more cost effective, less risky and importantly avoided the need for animal testing.
Animalcare says that as in previous years, it has set itself a target of launching four new veterinary medicines during the year. This launch is the first of those planned for the new financial year.
Stephen Wildridge, CEO of Animalcare Group, said: "We are very pleased to be able to add our new generic medicine Vitofyllin to our range of licensed veterinary medicines. The launch represents the culmination of the biggest development project undertaken by Animalcare and is the product of successful collaboration with members of our European partnership network."
MSD Animal Health (Merck in the US and Canada), has launched Finadyne (flunixin), the NSAID for cattle, as a pour on.
According to the company, Finadyne Transdermal is the world's first non-parasiticide cattle product to be made available as a pour-on.
Dr. Martin Behr, technical manager at MSD Animal Health said: “Finadyne Transdermal is uniquely designed for rapid absorption into the bloodstream and its antipyretic effect has been demonstrated as early as two hours after treatment. This is because innovative penetration enhancers are included in the formulation to improve the absorption of the active ingredient flunixin through the skin.”
The new product comes in pre-calibrated packaging and uses a bottle designed for easy application along an animal’s back.
Dr. Behr added: “It’s much simpler for farmers to treat cattle in this way – as opposed to administering an injection, which can also mean needle-site lesions that can reduce the value of a carcass or compromise hide quality.
“The time taken to handle and treat animals will be much reduced with a transdermal NSAID. There will also be a saving on syringes and needles.”
Finadyne Transdermal (POM-V) is available now from veterinary wholesalers. Further information is available from the MSD Animal Health veterinary support group on 01908 685685.
Dechra says necrotic enteritis can be treated with a variety of therapeutic antibiotics but that the first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like phenoxymethylpenicillin.
Phenocillin is an 800 mg/g powder for use in drinking water. It is lactose free, and Dechra says its high solubility makes it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Dechra Brand Manager Emma Jennings said: “Necrotic enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
"The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
"Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks."
For more information, visit: http://bit.ly/2nAboGU
The RCVS Charitable Trust has released the results of a survey that suggests a lack of available, high-quality research could be hampering the implementation of evidence-based medicine (EVM) in veterinary practice.
Of the 70 survey respondents, although 70% said they were familiar with the concepts of EVM, only 36% said that they always used EVM principles or that EVM principles were deeply embedded within their practices. When asked about the barriers to implementing EVM, many vets commented that there was a lack of high-quality research available to them.
Trust director, Cherry Bushell said: "This survey was relatively small as our intention is for it to help spark discussion at our forthcoming symposium 'The Sceptical Vet: Eminence or Evidence? Finding the best way forward for the veterinary profession'. We want to consider the possibility of developing a range of evidence-based resources for the veterinary profession, so it's interesting to hear vets commenting about the lack of an available, high-quality evidence base."
All those completing the Trust's survey were entered into a prize draw for a chance to have their travel expenses to the event reimbursed. Veterinary surgeon Ariel Brunn (top right) from Vets Now, Maidenhead, was the winner. She said: "I'm really looking forward to this Symposium and the discussion that will come with it - along with clinical governance, evidence-based practice provides a means to offer the best care for our veterinary patients. Having been a practising vet for less than 5 years, I'm excited to learn more about how EVM can be incorporated into veterinary practice and I'm certainly pleased to have won the prize draw to support my travel to this event."
This symposium will take place on Tuesday 30 October 2012, at Church House Conference Centre, London. A limited number of places are still available for practising veterinary surgeons and veterinary nurses only via the Trust (a.doorly@rcvstrust.org.uk or 0207 202 0741). For more information visit http://trust.rcvs.org.uk/grants-and-collaborations/the-sceptical-vet-eminence-or-evidence.
The RCVS has announced the results of the 2016 RCVS Council elections.
Current members Christopher Barker (2,838 votes), Amanda Boag (2,689 votes), Kit Sturgess (2,586 votes) and Stephen May (2,452 votes) were returned to four of the six available seats on RCVS Council. Melissa Donald and Lucie Goodwin are joining Council for the first time with 2,532 votes and 2,307 votes respectively.
The re-election of Stephen May means that he will serve as Junior Vice-President of the RCVS for 2016-17.
Voter turnout was down this year at 15.6% (or 4,403) of those eligible to vote, compared to 18.1% last year and the 17.2% average over the past 10 years.
Eleanor Ferguson, RCVS Acting Registrar, said: "I’d like to congratulate all those who were successfully elected, and re-elected, to Council, and thank all those who took part in this year’s elections – whether by standing as a candidate, casting a vote or submitting questions for the candidates to answer."
The successful candidates will take up their positions at RCVS Day – the College’s Annual General Meeting and Awards Day – on Friday 15 July 2016 at the Royal Institute of British Architects.
Each candidate in the elections was invited to produce a short video in which they answered questions put to them by fellow members of the professions and which appeared on the RCVS YouTube channel. The videos provided by the RCVS Council candidates received 1,169 views while those provided by the VN Council candidates received 779 views.
The elections were run on behalf of the College by Electoral Reform Services.
At the outset of the hearing, Mr Kashiv, from Vets & Pets, Broxbourne, denied all aspects of the charges against him. During the course of the inquiry, some heads of charge were not pursued and some he admitted, leaving the remaining heads of charge to be determined.
The charges concerned the treatment of a Scottish Terrier, called Tanzy, whose owner, Mrs Greenhill, brought her in to see Mr Kashiv on 5 March 2015. Mrs Greenhill was concerned about blood in Tanzy’s urine and swellings in her mammary glands. After carrying out a cytopathology test, Mr Kashiv advised Mrs Greenhill that Tanzy would require surgery to remove the mammary glands. There were no further tests conducted, and no alternatives to surgery suggested.
On 13 March another veterinary surgeon at Vets & Pets therefore undertook a right-side mammary strip on Tanzy, discharging her the following day. On 17 March Mrs Greenhill brought Tanzy back in for a post-operative check and was seen by a locum veterinary surgeon, who found her to be in good condition.
On 20 March Mrs Greenhill then became concerned about Tanzy’s deteriorating condition and returned her to see Mr Kashiv. He admitted Tanzy for observation over the weekend but did not conduct any further tests at that stage, apart from radiography on 22 March. The hospitalisation records were of poor quality and substantially incomplete.
On 23 March Mr Kashiv then informed Mrs Greenhill that Tanzy could be discharged, although he recommended an MRI scan to assist in the diagnosis; this was declined on cost grounds. He did not however explain clearly to Mrs Greenhill that Tanzy’s prognosis was bleak, and did not give adequate home care instructions.
Tanzy continued to deteriorate, and on 24 March Mrs Greenhill took Tanzy to the RSPCA Harmsworth Hospital where a veterinary surgeon conducted tests which showed that Tanzy was in renal failure. The veterinary surgeon then called Mrs Greenhill and recommended that Tanzy was put to sleep, which was then performed in Mrs Greenhill’s presence.
The Committee found that Mr Kashiv had failed to conduct the necessary investigations when Tanzy was admitted from 20 to 23 March 2015, being satisfied that, by the time Tanzy had been hospitalised for a period of three days, it was mandatory for a blood test to have been performed, given her marked deterioration.
The Committee also found while Mr Kashiv did express his opinion that Tanzy’s prognosis was poor, he did not give the full explanation required in the circumstances of this case to enable Mrs Greenhill to understand fully the prognosis. The Committee also considered that Tanzy was not in a fit state to be discharged on 23 March 2015, and that he had failed to keep sufficiently clear and/or detailed and/or accurate records.
After full consideration, the Committee found that Mr Kashiv’s actions amounted to serious professional misconduct, and was satisfied that his actions fell far short of the conduct to be expected of a reasonably competent veterinary surgeon in respect of heads of charge 1, 2 and 3 but not 4.
Although it was concerned "about the culture of care in the practice, in particular not having in place proper protocols and procedures and without necessary support from properly trained staff", in deciding on appropriate sanction, the Committee was satisfied that there were "a number of serious misjudgements by Mr Kashiv in this case".
The Committee decided to postpone judgement for a period of two years, whilst recommending that Mr Kashiv agree to undertake a structured programme to benefit his clinical practice including a Personal Development Plan, mentoring, practice visits, additional CPD and regular reports to the Disciplinary Committee.
Non-compliance with these undertakings may result in the hearing being resumed at a date earlier than the two-year period.
Stuart Drummond, Chairing the Disciplinary Committee and speaking on its behalf, said: "The Committee considers that Mr Kashiv is a dedicated veterinary surgeon, as evidenced by the large number of testimonials, and that he provides a valuable service to the community, particularly with rescue animals.
"Nevertheless, the Committee considers that there were a number of fundamental failings in Mr Kashiv’s clinical competence which are required to be addressed during the period of postponement. For the reasons set out above the Committee considers that Mr Kashiv’s clinical practice will benefit from a structured programme over the period of postponement, whilst protecting the welfare of animals, maintaining public confidence in the profession and declaring and upholding proper standards of conduct."
For the full charges, findings and decisions, see: http://www.rcvs.org.uk/concerns/disciplinary-hearings/
The course is aimed at veterinary professionals across Europe who want to advance their knowledge and diagnostic skills, progress their academic qualifications and gain recognition in their field.
The GPAdvCert in Small Animal Medicine is for veterinary surgeons who have already completed a General Practitioner Certificate in Small Animal Medicine (GPCertSAM) or a Postgraduate Certificate (PgC) in Small Animal Medicine.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme will be delivered in three, five-day blocks of training by globally recognised experts in three European training centres - Sheffield, UK; Porto, Portugal and Berlin, Germany. The programme includes a practical session in which delegates will perform an upper and lower gastrointestinal endoscopy under the guidance of their tutor.
David Babington MRCVS, Business Development Director of Improve International (pictured right), said: "Delegates attending our first GPAdvCert in Small Animal Medicine will enhance their skills and confidence in dealing with complex animal medicine cases. Each module will take their knowledge beyond Postgraduate Certificate level with more in-depth and advanced content covering topics as diverse as mycobacterial and ureteric disease. They will also learn how to design a detailed diagnostic plan and build an understanding of nuances in interpreting laboratory findings to enable them to manage cases requiring complex therapeutic management with confidence."
He added: "The qualification is a natural ‘next-step’ for veterinary surgeons wanting to further progress their knowledge of small animal internal medicine. It will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice and will also provide them with skills which they can pass onto their team."
Improve says the successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Medicine (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
Enalees offers a variety of point-of-care isothermal PCR animal diagnostics tests for canine, feline and equine infectious diseases, including parvo, leptospirosis, babesiosis and borreliosis.
The company says its tests are highly specific and sensitive and can detect the presence of a virus, parasite or microbe at a very early stage, without the use of expensive and complex equipment, within 30 minutes.
Lauren Craig is the General Manager of the new subsidiary. She said: “I will be coordinating the launch of the UK subsidiary and working with veterinary professionals to deliver Enalees’ unique portfolio offering in diagnostic testing and in clinic rapid PCR tests.
“I am incredibly excited for the challenge ahead and looking forward to working with a fantastic team with an important mission in this key market.”
www.enalees.com
In common with the various other telemedicine platforms which have come to market in recent months, the app will allow veterinary professionals to give help and advice to clients and maintain a revenue stream whilst maintaining social distancing.
VisioCare is highlighting a number of features over and above standard video conferencing, including the ability for the clinician to take photos, video and produce a case file that can be added to the clinical record. The system also allows vets to access the client's smartphone and zoom into areas that need to be examined or turn on a flashlight to improve visibility.
Visiocare says it has also been able to address limitations in clarity due to poor smartphone reception.
Linkyvet includes a payment module - which will be integrated free of charge for orders taken during April - so practices can charge for services provided remotely.
Alexander Arpino, Managing Director of Veterinary Insights, said: "During the current COVID-19 situation, Linkyvet has real potential for triage, as well as enabling routine consultations, without putting anyone at risk. It's good news for patient care, staff wellbeing and also ensuring that the practice remains a viable business that's still there for everyone to return to when life returns to normality.
"Outside crisis times, the tool has ongoing value, providing a great way to generate revenue from services such as advisory consultations and follow ups provided remotely and giving clients a convenient alternative to visiting the practice."
VisioCare Linkyvet is available as a standalone tool or can be included in a bundle with other VisioCare products such as VisioCare Consult, which provides explanatory animations and videos that support clinician recommendations and the myBuddy app, which provides a secure and personalised communication channel between clinic and pet owner.
For more information, visit www.visiocareservices.com or contact your VisioCare Business Development Manager: telephone 01403 800135 or email enquiries@visiocareservices.com.
However, when asked by VetSurgeon.org which audience - veterinary professionals, it's staff or the public - it was referring to, or what threats to safety and wellbeing were posed by X, the College refused point blank to answer.
So the real motivation remains unclear.
On the one hand, it could be a ridiculously over-sensitive move to protect its unknown audience from opinions that its staff find objectionable.
On the other hand, it could perfectly well be argued that short form social media reduces every discussion or debate to "I'm effing right and you're effing wrong", which is not appropriate for a scientific profession.
Equally, one could also argue that engaging in polarised debate online is not terribly good for one's wellbeing.
Or one could just argue that it's a terrible platform owned by a strangely meddlesome and interfering American.
However, given the College's strange refusal to expand on the reasons for its withdrawal, the first explanation seems more likely.
But who knows?
https://www.rcvs.org.uk/news-and-views/news/rcvs-statement-on-x-formerly-twitter/
The BVA has paid tribute to Lord Ballyedmond, founder of the veterinary pharmaceutical company Norbrook Laboratories, after he was killed in a helicopter crash in Norfolk last Thursday.
The life peer (pictured second from left collecting a business award in 2011) founded Norbrook over 40 years ago. It became one of the biggest manufacturers of animal health products globally, and now employs more than 1000 people. Dr. Edward Haughey, as he was previously known, was ennobled in 2004.
Following his death, Norbrook issued the following statement:
"It is with sincere sadness and deep regret that the Company confirms our founding Chairman and CEO, Lord Ballyedmond, was one of four people who tragically lost their lives in an aviation accident at Gillingham, Norfolk at approximately 7.30pm on Thursday 13 March 2014.
Norbrook management and staff also mourn the loss of their friends and colleagues Declan Small (Site Foreman), Captain Carl Dickerson (Pilot) and Captain Lee Hoyle (Pilot).
Our thoughts are with the immediate families and friends of the deceased who have requested privacy at this difficult time.
We take enormous pride in our Chairman's extraordinary legacy in establishing Norbrook as a global veterinary and pharmaceutical industry leader. Management will continue to advance his pioneering vision with a renewed vigor and determination befitting his memory."
BVA President Robin Hargreaves said: "We are deeply saddened to hear of the tragic passing of Lord Ballyedmond. He has been a great supporter of the veterinary profession and of BVA, and made an enormous contribution to veterinary medicine. He built opportunity for thousands of people in Northern Ireland and around the world and had a huge commercial and industrial presence throughout my whole career. Above all Lord Ballyedmond was a family man and all our thoughts are with his wife and children at this time."
The final deadline for paying the fee was 31 May 2019, with the 346 who did not pay being removed on 1 June 2019, compared to 308 last year.
Those who were removed from the Register but have subsequently paid to be restored are not named on the list.
The RCVS says it sent reminders to all MsRCVS, including emails and text messages, reminding them that the fee was due. Letters were sent to those members that the College does not have an email address or mobile telephone number for.
A list of those who have not paid their fee has now been published. Practices are encouraged to check the list to ensure that no employees are named.
The College also wants to remind veterinary surgeons that, although paying the fee is required to remain on the Register, to complete their registration in full they need to confirm they are compliant with the continuing professional development (CPD) requirement and complete the criminal disclosures form. Both of these are required by the Code of Professional Conduct and can be completed on the ‘My Account’ area.
Anyone with queries about completing the registration process should contact the Registration Department on 020 7202 0707 or registration@rcvs.org.uk.
The £11m project, which is backed by Mars Petcare, will include a cutting-edge imaging suite, state-of-the-art treatment facilities and a new linear accelerator.
Plans also include separate cat and dog waiting areas and client walking and comfort areas, seven operating theatres, 15 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and plans for a future hydrotherapy suite.
Daniel Hogan, operations manager at Southfields (pictured right), said: "This is a really exciting time for Southfields and our relocation will provide the region with one of the largest and best-equipped veterinary centres in the UK.
"The team and expertise have grown significantly in the past 18 months. We are very excited to continue to expand the unique and innovative offerings in patient care at our centre.
"Increasing in size will also enable us to provide a dedicated staff wellbeing area and an education centre and lecture hall, which will offer some very exciting qualifications and courses for the wider profession.
"Since our rebranding in 2017, we pride ourselves on leading the industry as a truly multidisciplinary centre with specialists from across the globe, including one of the most illustrious oncology teams in the country. Once this new site is launched, we will be able to offer an even more comprehensive service to our clients and patients."
For more information about Southfields, visit www.southfields.co.uk.
Ceva says the course is aimed at vets and nurses who want to build their confidence and take the lead in finding hypertension in cats in their clinic.
The course is hosted by Sarah Caney BVSc DSAM(Feline) MRCVS, one of the UK's leading specialists in feline medicine, and will cover things like finding out which cats need screening for feline hypertension, how to become confident in recommending a blood pressure check to owners, hints and tips on taking a reliable blood pressure measurement and handling cats calmly to reduce ‘situational hypertension’.
The course consists of four 30-minute recorded sessions including course notes and self-assessment questions for each module. Once completed, the delegate will receive a Hypertension Ambassador pin badge and a certificate for four hours’ CPD. The first 500 delegates to complete the course will be offered either a cat hide or an eye atlas.
The course can be completed online at any time. There are also weekly feline hypertension live sessions at 1pm, from Wednesday 4th March until Wednesday 25th March. They offer the opportunity for you to ask questions, but they're also recorded so you can watch them any time thereafter.
Suzanne Page BVSc MRCVS, cardio-nephrology-hypertension product manager at Ceva Animal Health, said: "Our HypertensionAmbassadors’ initiative will educate veterinary professionals on every aspect of feline hypertension to enable them to confidently talk to their clients about the condition, measure blood pressure in a cat-friendly way and offer advice on the different treatments available."
For more information, and to register, visit www.veterinarywebinars.com/feline-hypertension-ambassador.
Belfast-based Des Thompson MRCVS was presented with the first ever RCVS Queen's Medal by Her Majesty at Buckingham Palace this afternoon.
Des, pictured right showing off the new medal with his wife Rosalie, received two separate nominations for the medal, both citing his decades of active involvement in veterinary politics which includes being president of the RCVS, the British Small Animal Veterinary Association (BSAVA), the Society of Practising Veterinary Surgeons (SPVS) and the Northern Ireland Veterinary Association, among other organisations.
Also cited was his willingness to help other members of the profession, particularly young vets at the beginning of their careers, through his involvement with organisations such as the Young Vet Network in Northern Ireland and the Veterinary Benevolent Fund.
The Queen's Medal was launched in 2013, with the approval of Her Majesty as Patron of the RCVS, and is now the highest award that can be bestowed upon a veterinary surgeon in recognition of a particularly outstanding contribution to the profession. In receiving the medal, Des was joined by Professor Stuart Reid, current RCVS President, Colonel Neil Smith, immediate past President, and Gordon Hockey, RCVS Registrar.
Des said: "It was a complete honour and a wonderful experience to be received by Her Majesty at Buckingham Palace today, and I'm thrilled to have been awarded the RCVS Queen's Medal. Her Majesty was interested to hear about Northern Ireland, and the fact that I've been practising there since I qualified."
The company announced last month that from 1st January next year, practices will have to order companion animal and ruminant products via either MWI or NVS (who will also fulfil the order), but will be invoiced direct by MSD.
Pig products will join aquaculture and poultry products to be supplied directly to customers by MSD Animal Health.
In its announcement, the company said that the new structure would allow the company to enhance the customer experience and more quickly adapt to changes in the market to better serve its customers.
VetSurgeon.org contacted the company for further clarification about how the customer experience would be improved.
The company explained that the two main benefits of the new structure concern price visibility and stock control.
A spokesperson for the company said: "Currently, customers may get a discount from us and separately a discount from wholesaler. With our new distribution model we will invoice monthly and all discounts will be on one invoice, so it will be easier to determine the actual price paid."
The spokesperson explained that with the old model, once stock was sold to wholesalers it would be allocated to customers, so there would be some held by MSD, some allocated and some in distribution: "The benefit of the new model is we will have full oversight of stock as it will be in our own warehouses or with distribution partners. If there are disruptions in the market, we will have better awareness of in market demand and we can allocate stock appropriately".